ANALYSIS OF THE RANGE OF ANTI-PROSTATE CANCER MEDICINES REGISTERED IN THE REPUBLIC OF UZBEKISTAN

Authors

  • Tukhtasheva Visola Farmonovna Junior researcher, Department of Pharmacology and Clinical Pharmacology, Institute of Chemistry of Plant Substances, Pharmaceutical Sciences
  • Kambarov Husan Djahangirovich Doctor of pharmaceutical sciences, professor Professor of the Department of Pharmaceutical Work Organization Tashkent pharmaceutical institute, Tashkent sh
  • Zakhidova Lola Tishaevna Senior researcher of the department of pharmacology and clinical pharmacology of the Institute of Chemistry of Plant Substances

Keywords:

drugs against prostate cancer, group assortment, State Register, manufacturers, type of drug form

Abstract

This research work is devoted to studying the registration of drugs against prostate cancer.

The results of the years studied in the study showed that the consumer market of the Republic of Uzbekistan in the field of drugs against prostate cancer is usually satisfied with imported drugs by 55.6%. The analysis of registration in the State Register of medicines and medical products of the Republic of Uzbekistan showed that among foreign countries, Russia is leading with a share of 33.3%). The analysis of the drug form showed that all the received drugs are used in the form of sprays, lyophilisates, tablets, capsules and implant preparations. It was found that the capsule form of the drug was registered mainly by domestic manufacturers.

Downloads

Published

2023-09-22